BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 18251493)

  • 21. Enzymatic transition states, transition-state analogs, dynamics, thermodynamics, and lifetimes.
    Schramm VL
    Annu Rev Biochem; 2011; 80():703-32. PubMed ID: 21675920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzyme-ligand interactions that drive active site rearrangements in the Helicobacter pylori 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase.
    Ronning DR; Iacopelli NM; Mishra V
    Protein Sci; 2010 Dec; 19(12):2498-510. PubMed ID: 20954236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Third-generation immucillins: syntheses and bioactivities of acyclic immucillin inhibitors of human purine nucleoside phosphorylase.
    Clinch K; Evans GB; Fröhlich RF; Furneaux RH; Kelly PM; Legentil L; Murkin AS; Li L; Schramm VL; Tyler PC; Woolhouse AD
    J Med Chem; 2009 Feb; 52(4):1126-43. PubMed ID: 19170524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A beta-fluoroamine inhibitor of purine nucleoside phosphorylase.
    Mason JM; Murkin AS; Li L; Schramm VL; Gainsford GJ; Skelton BW
    J Med Chem; 2008 Sep; 51(18):5880-4. PubMed ID: 18800772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of second-generation transition state analogues of human purine nucleoside phosphorylase.
    Evans GB; Furneaux RH; Lewandowicz A; Schramm VL; Tyler PC
    J Med Chem; 2003 Nov; 46(24):5271-6. PubMed ID: 14613329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Over-the-barrier transition state analogues and crystal structure with Mycobacterium tuberculosis purine nucleoside phosphorylase.
    Lewandowicz A; Shi W; Evans GB; Tyler PC; Furneaux RH; Basso LA; Santos DS; Almo SC; Schramm VL
    Biochemistry; 2003 May; 42(20):6057-66. PubMed ID: 12755607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Picomolar transition state analogue inhibitors of human 5'-methylthioadenosine phosphorylase and X-ray structure with MT-immucillin-A.
    Singh V; Shi W; Evans GB; Tyler PC; Furneaux RH; Almo SC; Schramm VL
    Biochemistry; 2004 Jan; 43(1):9-18. PubMed ID: 14705926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acyclic ribooxacarbenium ion mimics as transition state analogues of human and malarial purine nucleoside phosphorylases.
    Taylor EA; Clinch K; Kelly PM; Li L; Evans GB; Tyler PC; Schramm VL
    J Am Chem Soc; 2007 Jun; 129(22):6984-5. PubMed ID: 17497780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the polyamine pathway with transition-state analogue inhibitors of 5'-methylthioadenosine phosphorylase.
    Evans GB; Furneaux RH; Schramm VL; Singh V; Tyler PC
    J Med Chem; 2004 Jun; 47(12):3275-81. PubMed ID: 15163207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Azetidine based transition state analogue inhibitors of N-ribosyl hydrolases and phosphorylases.
    Evans GB; Furneaux RH; Greatrex B; Murkin AS; Schramm VL; Tyler PC
    J Med Chem; 2008 Feb; 51(4):948-56. PubMed ID: 18251493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transition states and inhibitors of the purine nucleoside phosphorylase family.
    Taylor Ringia EA; Schramm VL
    Curr Top Med Chem; 2005; 5(13):1237-58. PubMed ID: 16305529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immucillins in Infectious Diseases.
    Evans GB; Tyler PC; Schramm VL
    ACS Infect Dis; 2018 Feb; 4(2):107-117. PubMed ID: 29151351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Tight binding transition state analogues of purine nucleoside phosphorylase--meaning, design and properties].
    Lewandowicz A
    Postepy Biochem; 2004; 50(3):218-27. PubMed ID: 15822751
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.